Avanos Medical, Inc. (AVNS) Stock Price

AVNSStock

$0.00−20.79%52W

Market Cap—

P/E—

PEG Ratio—

Div yield—

Beta0.25

AVNS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)95.68%

Price vs S&P 500 (4W)-1.20%

VGM Score52.52

P/CF (Annual)15.67x

Book Value / Share (Quarterly)$16.76

P/TBV (Annual)0.79x

Revenue Growth (3Y)-5.08%

Cash Flow / Share (Quarterly)$0.16

Price vs S&P 500 (YTD)114.17%

Gross Margin (TTM)50.05%

Net Profit Margin (TTM)-10.39%

EPS (TTM)$-1.61

10-Day Avg Trading Volume0.67M

EPS Excl Extra (TTM)$-1.61

Revenue Growth (5Y)-0.38%

EPS (Annual)$-1.57

ROI (Annual)-8.30%

Gross Margin (Annual)50.47%

Net Profit Margin (5Y Avg)-13.95%

Cash / Share (Quarterly)$1.41

Revenue Growth QoQ (YoY)8.78%

ROA (Last FY)-6.79%

Revenue Growth TTM (YoY)3.87%

EBITD / Share (TTM)$-0.50

ROE (5Y Avg)-11.48%

Operating Margin (TTM)-8.80%

Cash Flow / Share (Annual)$0.93

P/B Ratio1.50x

P/B Ratio (Quarterly)0.83x

Net Income / Employee (Annual)$-31,900

EV / Revenue (TTM)1.68x

Net Interest Coverage (TTM)-13.39x

ROA (TTM)-7.03%

EPS Growth QoQ (YoY)-23.83%

EV / EBITDA (TTM)15.23x

EPS Incl Extra (Annual)$-1.57

Current Ratio (Annual)2.15x

Quick Ratio (Quarterly)1.29x

3-Month Avg Trading Volume1.30M

52-Week Price Return-20.79%

EV / Free Cash Flow (Annual)27.92x

Revenue / Employee (TTM)$313,000

Tangible BV / Share (Quarterly)$14.30

P/S Ratio (Annual)1.67x

Asset Turnover (Annual)0.65x

52-Week High$25.49

Operating Margin (5Y Avg)-11.13%

EPS Excl Extra (Annual)$-1.57

CapEx CAGR (5Y)9.36%

Tangible BV CAGR (5Y)-9.68%

26-Week Price Return102.51%

Quick Ratio (Annual)1.17x

13-Week Price Return1.38%

Total Debt / Equity (Annual)0.13x

Current Ratio (Quarterly)2.48x

Enterprise Value$1.20B

Revenue / Share Growth (5Y)0.25%

Asset Turnover (TTM)0.68x

Book Value / Share Growth (5Y)-8.58%

Revenue / Employee (Annual)$306,600

Inventory Turnover (Annual)2.42x

Pretax Margin (Annual)-9.44%

Cash / Share (Annual)$1.93

3-Month Return Std Dev4.46%

Gross Margin (5Y Avg)53.22%

Net Income / Employee (TTM)$-32,500

EBITDA Interim CAGR (5Y)-2.17%

ROE (Last FY)-9.37%

Net Interest Coverage (Annual)-11.89x

EPS Basic Excl Extra (Annual)$-1.57

P/FCF (TTM)24.75x

Receivables Turnover (TTM)6.91x

EV / Free Cash Flow (TTM)160.44x

Total Debt / Equity (Quarterly)0.13x

EPS Incl Extra (TTM)$-1.61

Receivables Turnover (Annual)6.06x

ROI (TTM)-8.45%

P/S Ratio (TTM)1.64x

Pretax Margin (5Y Avg)-12.10%

Revenue / Share (Annual)$15.14

Tangible BV / Share (Annual)$14.22

Forward P/E24.99x

Price vs S&P 500 (52W)-30.04%

Year-to-Date Return122.53%

5-Day Price Return0.00%

EPS Normalized (Annual)$-1.57

ROA (5Y Avg)-8.25%

Net Profit Margin (Annual)-10.40%

Month-to-Date Return0.44%

Cash Flow / Share (TTM)$0.94

EBITD / Share (Annual)$-0.49

Operating Margin (Annual)-8.78%

LT Debt / Equity (Annual)0.12x

P/CF (TTM)31.90x

ROI (5Y Avg)-9.95%

LT Debt / Equity (Quarterly)0.11x

EPS Basic Excl Extra (TTM)$-1.61

P/TBV (Quarterly)0.98x

P/B Ratio (Annual)0.67x

Inventory Turnover (TTM)2.56x

Pretax Margin (TTM)-9.54%

Book Value / Share (Annual)$16.75

Price vs S&P 500 (13W)-2.52%

Beta0.25x

P/FCF (Annual)27.16x

Revenue / Share (TTM)$15.07

ROE (TTM)-9.55%

52-Week Low$10.64

vGradeB

gGradeD

mGradeB

vgmGradeC

AVNS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q1 2026	May 5, 2026	$0.14	$0.22	+57.14%(+$0.08)
Q4 2025	Feb 24, 2026	$0.25	$0.29	+16.00%(+$0.04)
Q3 2025	Nov 5, 2025	$0.12	$0.22	+83.33%(+$0.10)
Q2 2025	Aug 5, 2025	$0.15	$0.17	+13.33%(+$0.02)

AVNS Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

2.17

Industry Peers — Orthopedic & Prosthetic Devices(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
AVNSAvanos Medical, Inc.	B	D	B	1.6x	-0.4%	50.0%	-8.8%	$0.00
ISRGIntuitive Surgical Inc.	D	B	B	13.7x	18.2%	66.7%	31.3%	$426.70
EWEdwards Lifesciences Corp	D	C	B	7.7x	6.7%	77.8%	18.2%	$86.60
STESTERIS plc	C	C	B	3.6x	13.8%	44.4%	18.9%	$222.66
ZBHZimmer Biomet Holdings, Inc.	B	C	B	2.1x	3.2%	69.9%	14.2%	$94.98
SNNSmith & Nephew plc	B	C	C	1.9x	6.2%	68.2%	12.9%	$29.06
ALGNAlign Technology Inc	B	D	C	2.5x	10.3%	69.0%	13.2%	$147.31
MSAMine Safety Incorporated	C	C	B	3.5x	6.8%	47.6%	21.2%	$179.05
ESTAEstablishment Labs Holdings Inc.	F	A	C	7.2x	20.0%	70.5%	-7.6%	$59.18
ENOVEnovis Corporation	B	D	C	0.5x	-6.0%	61.4%	-45.1%	$19.59
CDRECadre Holdings, Inc.	B	C	C	1.6x	8.6%	41.8%	10.1%	$26.38
AVRAnteris Technologies Global Corp. Common Stock	D	C	C	263.0x	—	75.0%	-4738.4%	$6.05
SMTISanara MedTech Inc. Common Stock	D	C	B	2.8x	45.9%	93.0%	7.7%	$33.16
INGNInogen Inc	B	D	C	0.5x	2.5%	44.5%	-8.7%	$6.25
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	F	D	C	6.3x	5.0%	29.2%	2.9%	$2.08
LAKELakeland Industries Inc	B	D	D	0.5x	3.9%	32.6%	-4.1%	$9.09
CNXUConexeu Sciences Inc. Common Stock	—	—	F	—	—	—	—	$3.06
NTRBNutriband Inc. Common Stock	F	D	B	46.7x	16.6%	33.1%	-435.6%	$6.22
SPAISafe Pro Group Inc. Common Stock	F	A	D	23.3x	—	62.2%	-513.8%	$3.30
APTAlpha Pro Tech, Ltd.	A	D	B	0.9x	-10.4%	37.5%	7.5%	$5.55
COCHEnvoy Medical, Inc. Class A Common Stock	F	F	C	249.8x	—	-385.5%	-11411.1%	$0.67
MYOMyomo Inc.	B	B	B	1.1x	40.1%	68.3%	-27.1%	$1.20
MLSSMilestone Scientific, Inc. Common Stock	D	C	C	3.1x	10.5%	70.2%	-43.6%	$0.33
LFWDLifeward Ltd. Ordinary Shares	A	C	C	1.1x	38.1%	32.9%	-125.5%	$6.00
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	F	196.5x	—	-0.4%	-9352.8%	$1.90
RGNTRegentis Biomaterials Ltd.	—	—	D	—	—	—	—	$1.49
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	D	F	C	17.6x	-17.3%	-147.6%	-3329.1%	$3.63
BBLGBone Biologics Corp Common Stock	—	—	F	—	—	—	—	$0.40
FEEDENvue Medical, Inc. Common Stock	—	F	F	0.2x	—	-26.1%	-1362.7%	$0.37
BBLGWBone Biologics Corp Warrants	—	—	D	—	—	—	—	$7.70
COCHWEnvoy Medical, Inc Warrant	—	—	D	—	—	—	—	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	—	—	—	—	$0.55

About Avanos Medical, Inc.

Avanos Medical Inc is a medical technology company specializing in pain management and patient care solutions. The company operates two primary segments: Specialty Nutrition Systems, which provides enteral feeding and neonatal products, and Pain Management and Recovery, which offers surgical pain solutions, pain pumps, and radiofrequency ablation treatments for chronic pain management.